GPhA Applauds House Passage Of U.S.-Peru Free Trade Agreement

The Generic Pharmaceutical Association (GPhA) praised the House of Representatives for its strong bipartisan approval of the U.S.-Peru Free Trade Agreement, which proves that our nation’s free trade agreements can foster innovation while also ensuring that our trading partners have access to safe and affordable medicines. [click link for full article]

More: continued here

Filed under: Pharma Industry on November 11th, 2007